Post-lockdown impact of the COVID-19 pandemic on patients affected by chronic diseases in Europe

2021-10-01T08:50:21+02:00 October 1st, 2021|Featured, Publications|

  • Presented at International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2013

  • Collaborator : Scientific committee

  • Authors: Alexis Astruc, Bruno Halioua, Jean Zetlaoui, Meryem Harrizi, Alexis Bombezin–Domino, Lise Radoszycki

Patients with Chronic Medical Conditions (CMC) require regular access to healthcare professionals and have to take long-term treatments. The COVID-19 pandemic may affect their clinical outcomes.

Objective:  Evaluate the impact of the COVID-19 epidemic on patients with CMC in Europe.